Birgitte DenlowGCP Advisor Specialist, Global Clinical Quality & Intelligence at Novo Nordisk, Denmark
Agenda Sessions
Novo Nordisk’s learning's from implementing DTP (Shipment of IMP from site to patients’ home)
, 10:25View SessionLIVE Panel, Q&A and Audience Interaction: Interaction between all stakeholders on decentralized/hybrid trials
, 12:45View SessionLIVE Panel, Q&A and Audience Interaction: Interaction between all stakeholders on decentralized/hybrid trials
, 12:45View Session